128 related articles for article (PubMed ID: 10851091)
61. The ubiquitin-proteasome pathway in distal myopathy with rimmed vacuoles.
Jimi T; Wakayama Y
Intern Med; 1998 Sep; 37(9):722-3. PubMed ID: 9804076
[No Abstract] [Full Text] [Related]
62. Ubiquitin junction, what's your function?
Lee TA; Tyers M
Genome Biol; 2001; 2(10):REPORTS4025. PubMed ID: 11597332
[TBL] [Abstract][Full Text] [Related]
63. Can impaired proteasome function cause aneuploidy?
Wojcik C
Trends Cell Biol; 2001 Jun; 11(6):241. PubMed ID: 11356349
[No Abstract] [Full Text] [Related]
64. Proteasome and cell cycle. Evidence for a regulatory role of the protease on mitotic cyclins in yeast.
Richter-Ruoff B; Wolf DH
FEBS Lett; 1993 Dec; 336(1):34-6. PubMed ID: 8262212
[TBL] [Abstract][Full Text] [Related]
65. Proteolysis problems implicated in neurodegenerative diseases.
Bradbury J
Lancet; 2001 May; 357(9269):1679. PubMed ID: 11425382
[No Abstract] [Full Text] [Related]
66. A role for the proteasome in HIV infection.
Perks B
Trends Immunol; 2001 Jan; 22(1):12. PubMed ID: 11286680
[No Abstract] [Full Text] [Related]
67. CDK2 and PKA mediated-sequential phosphorylation is critical for p19INK4d function in the DNA damage response.
Marazita MC; Ogara MF; Sonzogni SV; Martí M; Dusetti NJ; Pignataro OP; Cánepa ET
PLoS One; 2012; 7(4):e35638. PubMed ID: 22558186
[TBL] [Abstract][Full Text] [Related]
68. Mice lacking cyclin-dependent kinase inhibitor p19Ink4d show strain-specific effects on male reproduction.
Buchold GM; Magyar PL; O'Brien DA
Mol Reprod Dev; 2007 Aug; 74(8):1008-20. PubMed ID: 17393423
[TBL] [Abstract][Full Text] [Related]
69. E2F1 induces p19INK4d, a protein involved in the DNA damage response, following UV irradiation.
Carcagno AL; Giono LE; Marazita MC; Castillo DS; Pregi N; Cánepa ET
Mol Cell Biochem; 2012 Jul; 366(1-2):123-9. PubMed ID: 22476863
[TBL] [Abstract][Full Text] [Related]
70. Ubiquitin, proteasomes, and the regulation of intracellular protein degradation.
Hochstrasser M
Curr Opin Cell Biol; 1995 Apr; 7(2):215-23. PubMed ID: 7612274
[TBL] [Abstract][Full Text] [Related]
71. Targets for cancer therapy in the cell cycle pathway.
Rao RN
Curr Opin Oncol; 1996 Nov; 8(6):516-24. PubMed ID: 8971472
[TBL] [Abstract][Full Text] [Related]
72. p19INK4D and cell death.
Tavera-Mendoza LE; Wang TT; White JH
Cell Cycle; 2006 Mar; 5(6):596-8. PubMed ID: 16582618
[TBL] [Abstract][Full Text] [Related]
73. The proteasome in cancer biology and treatment.
Pajonk F; McBride WH
Radiat Res; 2001 Nov; 156(5 Pt 1):447-59. PubMed ID: 11604057
[TBL] [Abstract][Full Text] [Related]
74. INK4 Family -A promising target for 'gene-regulating chemoprevention' and 'molecular-targeting prevention' of cancer.
Matsuzaki Y; Sakai T
Environ Health Prev Med; 2005 Mar; 10(2):72-7. PubMed ID: 21432144
[TBL] [Abstract][Full Text] [Related]
75. Phosphorylation-induced unfolding regulates p19
Kumar A; Gopalswamy M; Wolf A; Brockwell DJ; Hatzfeld M; Balbach J
Proc Natl Acad Sci U S A; 2018 Mar; 115(13):3344-3349. PubMed ID: 29531090
[TBL] [Abstract][Full Text] [Related]
76. Targeting the cell cycle for cancer therapy.
Carnero A
Br J Cancer; 2002 Jul; 87(2):129-33. PubMed ID: 12107831
[TBL] [Abstract][Full Text] [Related]
77. Nuclear translocation of p19INK4d in response to oxidative DNA damage promotes chromatin relaxation.
Sonzogni SV; Ogara MF; Castillo DS; Sirkin PF; Radicella JP; Cánepa ET
Mol Cell Biochem; 2015 Jan; 398(1-2):63-72. PubMed ID: 25204969
[TBL] [Abstract][Full Text] [Related]
78. CIP/KIP and INK4 families as hostages of oncogenic signaling.
Csergeová L; Krbušek D; Janoštiak R
Cell Div; 2024 Apr; 19(1):11. PubMed ID: 38561743
[TBL] [Abstract][Full Text] [Related]
79. Metabolic oscillations during cell-cycle progression.
Icard P; Simula L
Trends Endocrinol Metab; 2022 Jul; 33(7):447-450. PubMed ID: 35534337
[TBL] [Abstract][Full Text] [Related]
80. Presentation and management of diverse cutaneous reactions after cyclin-dependent kinase 4/6 inhibitor use.
Amigo M; Hoffman K; Chung C; Lustberg M; Wesolowski R; VanDeusen J; Stover D; Suarez GT; Cherian M; Kaffenberger B; Dulmage B
J Am Acad Dermatol; 2022 Jun; 86(6):1346-1348. PubMed ID: 33961922
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
